New Taiwan FDA to start operations early next year, streamline reviews
This article was originally published in SRA
Executive Summary
An official from Taiwan’s Center for Drug Evaluation has said that plans for a new Taiwan Food and Drug Administration are moving forward, with the new agency expected to start operations in January 2010. At the Drug Information Association’s 45th annual meeting in San Diego, US, on 21-25 June, Chih-Hwa Wallace Lin, director of the CDE’s Division of Resource Development, said that industry could also expect to see a more streamlined new drug application review process in 2010, as well as modifications to the way clinical trials are regulated in Taiwan.
You may also be interested in...
Global medtech alliance approves six new member associations
An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.
Global medtech alliance approves six new member associations
An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.
US FDA scrutiny of DTC genetic tests continues
The US FDA's devices unit has written to three genetic testing companies warning them that they may be marketing their products and services without clearance by the agency.